Correlation Between Acumen Pharmaceuticals and NYSE Declining

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and NYSE Declining at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and NYSE Declining into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and NYSE Declining Stocks, you can compare the effects of market volatilities on Acumen Pharmaceuticals and NYSE Declining and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of NYSE Declining. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and NYSE Declining.

Diversification Opportunities for Acumen Pharmaceuticals and NYSE Declining

-0.23

Correlation Coefficient

Acumen Pharmaceuticals  NYSE Declining

Very good diversification

The 3 months correlation between Acumen and NYSE is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and NYSE Declining Stocks in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NYSE Declining Stocks and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with NYSE Declining. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NYSE Declining Stocks has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and NYSE Declining go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and NYSE Declining

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the NYSE Declining. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 10.68 times less risky than NYSE Declining. The stock trades about -0.09 of its potential returns per unit of risk. The NYSE Declining Stocks is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  181,100  in NYSE Declining Stocks on September 20, 2024 and sell it today you would earn a total of  81,700  from holding NYSE Declining Stocks or generate 45.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  NYSE Declining Stocks

Pair Trading with Acumen Pharmaceuticals and NYSE Declining

The main advantage of trading using opposite Acumen Pharmaceuticals and NYSE Declining positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, NYSE Declining can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NYSE Declining will offset losses from the drop in NYSE Declining's long position.

The idea behind Acumen Pharmaceuticals and NYSE Declining Stocks pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.